<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment for children with symptomatic lead poisoning or blood lead level 70 mcg/dL or greater</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment for children with symptomatic lead poisoning or blood lead level 70 mcg/dL or greater</h1>
<div class="graphic"><div class="figure"><div class="ttl">Treatment for children with symptomatic lead poisoning or blood lead level 70 mcg/dL or greater</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1" colspan="2">Symptomatic or asymptomatic with blood lead level ≥70 mcg/dL (3.38 micromol/L)</td> </tr> <tr> <td>(a)</td> <td>The children should be hospitalized immediately.</td> </tr> <tr> <td>(b)</td> <td>Report the case as well as any other children at possible risk of lead poisoning to appropriate health authorities.</td> </tr> <tr> <td>(c)</td> <td> <p>Perform history, physical examination and baseline studies (abdominal radiograph, CBC with differential, blood lead level, erythrocyte protoporphyrin, serum electrolytes, BUN, creatinine, serum calcium, AST, ALT, urinalysis, and, in patients with encephalopathy, computed tomography of the head).</p> </td> </tr> <tr> <td>(d) </td> <td>In consultation with an expert in the management of pediatric lead poisoning, administer BAL to symptomatic patients. Asymptomatic patients may receive succimer.<sup>¶</sup> </td> </tr> <tr> <td>(e) </td> <td>In symptomatic patients, after BAL is started, and once urine output is established, begin CaNa<sub>2</sub>EDTA intravenously. In asymptomatic patients, begin CaNa<sub>2</sub>EDTA intravenously 48 hours after succimer is started.<sup>¶</sup> </td> </tr> <tr> <td>(f)</td> <td>During chelation, monitor serum electrolytes, calcium, BUN, creatinine, complete blood count, AST, ALT and urinalysis daily; measure blood lead level on day 3 and, if applicable, day 5.</td> </tr> <tr> <td>(g) </td> <td>Wait two days after completion, recheck lead levels, and administer a second course if Pb levels &gt;45 mcg/dL (2.17 micromol/L). A third course may be necessary if lead levels remain elevated &gt;45 mcg/dL (2.17 micromol/L) 5-7 days after the second course.</td> </tr> <tr> <td>(h) </td> <td>Succimer alone may be used for the second or third course of chelation in patients who are asymptomatic and whose lead levels are between 45 (2.17 micromol/L) and 70 mcg/dL (3.38 micromol/L) if they are cooperative, lead-safe housing is assured, and good compliance is anticipated.<sup>¶</sup></td> </tr> <tr> <td>(i)</td> <td>Provide parents with educational and nutritional counseling.</td> </tr> <tr> <td>(j)</td> <td>Do not discharge until environmental investigation is completed and recommendations on care at home are made. Patients must be discharged to a lead-safe environment.</td> </tr> <tr> <td>(k) </td> <td>Ensure monitoring of lead levels after discharge by a clinician with expertise in pediatric lead poisoning.</td> </tr> </tbody></table></div><div class="graphic_lgnd">CBC: complete blood count; BAL: British anti-Lewisite (dimercaprol); IM: intramuscular; CaNa2EDTA: calcium disodium edetate; Pb: lead; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase.</div><div class="graphic_footnotes">*For suggested laboratory studies during the initial evaluation of children with severe lead poisoning, refer to UpToDate topics on the management of childhood lead poisoning . <br/><sup>​¶</sup>For dosing and administration of chelation agents for children with severe lead poisoning, refer to UpToDate topics on the management of childhood lead poisoning. </div><div id="graphicVersion">Graphic 52132 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
